What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)
MASC 背后的秘密:在乳腺类似分泌性癌 (MASC) 中鉴定出 ETV6-NTRK3 后,恩曲替尼的临床反应和获得性耐药性
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdw042
Drilon, A; Li, G; Dogan, S; Gounder, M; Shen, R; Arcila, M; Wang, L; Hyman, D M; Hechtman, J; Wei, G; Cam, N R; Christiansen, J; Luo, D; Maneval, E C; Bauer, T; Patel, M; Liu, S V; Ou, S H I; Farago, A; Shaw, A; Shoemaker, R F; Lim, J; Hornby, Z; Multani, P; Ladanyi, M; Berger, M; Katabi, N; Ghossein, R; Ho, A L